naproxen has been researched along with Prodromal Characteristics in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Breitner, J; Etienne, P; Lafaille-Magnan, ME; Leoutsakos, J; Madjar, C; Meyer, PF; Poirier, J; Rosa-Neto, P; Savard, M; Tremblay-Mercier, J | 1 |
1 trial(s) available for naproxen and Prodromal Characteristics
| Article | Year |
|---|---|
INTREPAD: A randomized trial of naproxen to slow progress of presymptomatic Alzheimer disease.
Topics: Aged; Alzheimer Disease; Anti-Inflammatory Agents, Non-Steroidal; Disease Progression; Double-Blind Method; Female; Humans; Male; Middle Aged; Naproxen; Prodromal Symptoms; Treatment Outcome | 2019 |